サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1330996

腎除神経技術の世界市場

Renal Denervation Technologies
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 107 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
腎除神経技術の世界市場
出版日: 2023年08月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 107 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

腎除神経技術の世界市場は2030年までに28億米ドルに達する

変化するポストCOVID-19のビジネス環境において、2022年に1億8,380万米ドルと推定される腎除神経技術の世界市場は、2030年までに28億米ドルの改定規模に達すると予測され、分析期間2022-2030年のCAGRは40.6%で成長すると予測されます。本レポートで分析したセグメントの1つである高周波ベースは、CAGR 40.2％を記録し、分析期間終了までに20億米ドルに達すると予測されています。現在進行中のパンデミック後の回復を考慮し、超音波ベースのセグメントの成長は今後8年間のCAGRを42.6％に修正しました。

米国市場は4,700万米ドル、中国はCAGR 52.6％で成長予測

米国の腎除神経技術市場は、2022年には4,700万米ドルになると推定されます。世界第2位の経済大国である中国は、2022年から2030年までの分析期間においてCAGR 52.6%で推移し、2030年までに2億4,990万米ドルの市場規模に達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ33.8%と37.9%の成長が予測されています。欧州では、ドイツがCAGR約38.3%で成長すると予測されています。

調査対象企業の例

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Medtronic PLC
  • Terumo Corporation
  • Otsuka Medical Devices Co., Ltd.
  • Ablative Solutions, Inc.
  • Mercator MedSystems, Inc.
  • Autonomix Medical

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • ラテンアメリカ
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP14407

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Renal Denervation Technologies Market to Reach $2.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Renal Denervation Technologies estimated at US$183.8 Million in the year 2022, is projected to reach a revised size of US$2.8 Billion by 2030, growing at a CAGR of 40.6% over the analysis period 2022-2030. Radiofrequency Based, one of the segments analyzed in the report, is projected to record a 40.2% CAGR and reach US$2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Ultrasound Based segment is readjusted to a revised 42.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $47 Million, While China is Forecast to Grow at 52.6% CAGR

The Renal Denervation Technologies market in the U.S. is estimated at US$47 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$249.9 Million by the year 2030 trailing a CAGR of 52.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 33.8% and 37.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 38.3% CAGR.

Select Competitors (Total 13 Featured) -

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Medtronic PLC
  • Terumo Corporation
  • Otsuka Medical Devices Co., Ltd.
  • Ablative Solutions, Inc.
  • Mercator MedSystems, Inc.
  • Autonomix Medical

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Renal Denervation Technologies - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Hypertension - A Chronic Disease
    • Impact of Covid-19 and a Looming Global Recession
    • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • Covid-19 Causes Major Dent to a Growing Renal Denervation Technologies Market
    • A Prelude to Renal Denervation
    • The Evolution
    • Global Renal Denervation Technologies Market Set to Witness Rapid Growth
    • Developed Regions Dominate, Asia-Pacific Exhibits Fastest Growth
    • Europe - A Major Market
    • Radiofrequency Ablation Dominates the Market, Ultrasound to Register Fastest Growth
    • Radiofrequency Based Renal Denervation
    • Ultrasound Based Renal Denervation
    • Micro-Infusion Based Renal Denervation
    • Stringent Regulatory Environment
    • Growth Deterrents
    • Competitive Landscape
    • Select List of Approved Renal Denervation Devices
    • Symplicity Renal Denervation System Leads
    • Renal Denervation Devices
    • EnligHTN
    • Iberis
    • Paradise
    • Symplicity
    • Vessix (V2)
    • Recent Market Activity
    • Recent Clinical Trials in Nerve Denervation Technologies
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Hypertension Drives the Market for Renal Denervation Technologies Market
    • Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years
    • Ageing Demographics to Propel the Demand for Renal Denervation Devices
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Rising Obesity Incidence Spurs the Demand for Renal Denervation Technologies Market
    • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
    • Uptrend in Healthcare Spending Creates Fertile Environment
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
    • Regulatory Approvals to Remain a Focal Point
    • Breakthrough Designations for Renal Denervation Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Renal Denervation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Renal Denervation Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Radiofrequency Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Radiofrequency Based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ultrasound Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Ultrasound Based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Micro-Infusion Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Micro-Infusion Based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2023 & 2030
    • TABLE 9: World Renal Denervation Technologies Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 10: USA Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 11: USA 8-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2023 & 2030
  • CANADA
    • TABLE 12: Canada Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 13: Canada 8-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2023 & 2030
  • JAPAN
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 14: Japan Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 15: Japan 8-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2023 & 2030
  • CHINA
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 16: China Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 17: China 8-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2023 & 2030
  • EUROPE
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 18: Europe Recent Past, Current & Future Analysis for Renal Denervation Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 19: Europe 8-Year Perspective for Renal Denervation Technologies by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 20: Europe Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 21: Europe 8-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2023 & 2030
  • FRANCE
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 22: France Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 23: France 8-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2023 & 2030
  • GERMANY
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 24: Germany Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 25: Germany 8-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2023 & 2030
  • ITALY
    • TABLE 26: Italy Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Italy 8-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2023 & 2030
  • UNITED KINGDOM
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 28: UK Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 29: UK 8-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2023 & 2030
  • SPAIN
    • TABLE 30: Spain Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 31: Spain 8-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2023 & 2030
  • RUSSIA
    • TABLE 32: Russia Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Russia 8-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 34: Rest of Europe Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Rest of Europe 8-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 36: Asia-Pacific Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Asia-Pacific 8-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2023 & 2030
  • LATIN AMERICA
    • Renal Denervation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 38: Latin America Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Latin America 8-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 40: Rest of World Recent Past, Current & Future Analysis for Renal Denervation Technologies by Technology - Radiofrequency Based, Ultrasound Based and Micro-Infusion Based - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 41: Rest of World 8-Year Perspective for Renal Denervation Technologies by Technology - Percentage Breakdown of Value Revenues for Radiofrequency Based, Ultrasound Based and Micro-Infusion Based for the Years 2023 & 2030

IV. COMPETITION